Journal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 52, Issue 1, Pages 60-68Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2008.02.077
Keywords
-
Categories
Funding
- NCI NIH HHS [P30 CA015083, P30 CA015083-309015] Funding Source: Medline
- NHLBI NIH HHS [P01 HL076611-01A19002, R01 HL083231-01A1, R01 HL036634-13, P01 HL076611-01A10002, R01 HL036634-21, P01 HL076611-03, P01HL76611, R01 HL083231-04, P01 HL076611, R01 HL036634-17, R01HL36634, R01 HL036634, R01 HL083231, R01HL8373] Funding Source: Medline
Ask authors/readers for more resources
Objectives Our aim was to design, synthesize and test in vivo and in vitro a new chimeric peptide that would combine the beneficial properties of 2 distinct natriuretic peptides with a biological profile that goes beyond native peptides. Background Studies have established the beneficial vascular and antiproliferative properties of C-type natriuretic peptide (CNP). While lacking renal actions, CNP is less hypotensive than the cardiac peptides atrial natriuretic peptide and B-type natriuretic peptide but unloads the heart due to venodilation. Dendroaspis natriuretic peptide is a potent natriuretic and diuretic peptide that is markedly hypotensive and functions via a separate guanylyl cyclase receptor compared with CNP. Methods Here we engineered a novel chimeric peptide CD-NP that represents the fusion of the 22-amino acid peptide CNP together with the 15-amino acid linear C-terminus of Dendroaspis natriuretic peptide. We also determined in vitro in cardiac fibroblasts cyclic guanosine monophosphate- activating and antiproliferative properties of CD-NP. Results Our studies demonstrate in vivo that CD-NP is natriuretic and diuretic, glomerular filtration rate enhancing, cardiac unloading, and renin inhibiting. CD-NP also demonstrates less hypotensive properties when compared with B-type natriuretic peptide. In addition, CD-NP in vitro activates cyclic guanosine monophosphate and inhibits cardiac fibroblast proliferation. Conclusions The current findings advance an innovative design strategy in natriuretic peptide drug discovery and development to create therapeutic peptides with favorable properties that may be preferable to those associated with native natriuretic peptides.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available